Becton, Dickinson (BDX) is a medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BDX's fundamental rating was just raised by a sell-side firm to "Overweight" with a $275 price target. Let's check out the charts and indicators.
More from Investing
Looming price data and expected volatility could offer opportunities for very short-term traders, but building longer-term positions is a tougher task.
As our appetite expands to 'take what we can get' investments, let's look at three funds from Global X and see how they stack up against major index funds.
Here's the shift in the narrative I expect over the coming days.
BMBL has a date with earnings on Wednesday, and the charts say investors should refrain from flirting with the stock.